Overcoming chemo/radio-resistance of pancreatic cancer by inhibiting STAT3 signaling.
Wu, Xiaoqing; Tang, Wenhua; Marquez, Rebecca T; Li, Ke; Highfill, Chad A; He, Fengtian; Lian, Jiqin; Lin, Jiayuh; Fuchs, James R; Ji, Min; Li, Ling; Xu, Liang.
; 7(10): 11708-23, 2016 Mar 08.
Artigo em Inglês | MEDLINE | ID: mdl-26887043
Curcumin analogs: Their roles in pancreatic cancer growth and metastasis.
Chemotherapy and radiotherapy for advanced pancreatic cancer.
Therapeutic Potential of Curcumin in Treatment of Pancreatic Cancer: Current Status and Future Perspectives.
Interleukin-27 inhibits malignant behaviors of pancreatic cancer cells by targeting M2 polarized tumor associated macrophages.
Insights into gemcitabine resistance and the potential for therapeutic monitoring.
Hyaluronic Acid Engineered Nanomicelles Loaded with 3,4-Difluorobenzylidene Curcumin for Targeted Killing of CD44+ Stem-Like Pancreatic Cancer Cells.
WITHDRAWN: Chemotherapy and radiotherapy for inoperable advanced pancreatic cancer.
PEG Grafted-Nanodiamonds for the Delivery of Gemcitabine.
Curcumin sensitizes pancreatic cancer cells to gemcitabine by attenuating PRC2 subunit EZH2, and the lncRNA PVT1 expression.
Meta-analysis on resected pancreatic cancer: a comparison between adjuvant treatments and gemcitabine alone.